Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

2 High-Yield Dividend Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749670/time-to-buy.jpg
2 High-Yield Dividend Stocks to Buy in October

High-yield dividend stocks are a powerful way to boost a portfolio's annual performance. By reinvesting the dividend and regularly buying more shares, these stocks can produce impressive returns

2 High-Yield Dividend Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749670/time-to-buy.jpg
2 High-Yield Dividend Stocks to Buy in October

High-yield dividend stocks are a powerful way to boost a portfolio's annual performance. By reinvesting the dividend and regularly buying more shares, these stocks can produce impressive returns

3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years: https://g.foolcdn.com/editorial/images/749431/a-person-counting-money-in-their-living-room.jpg
3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years

If you're investing in a dividend stock, there's more than just the yield and the payout ratio to consider. It's also important to look at dividend increases -- whether the company has been making

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Intellia Therapeutics Could Rise 167%, Per Wall Street, But Is It a Buy?: https://g.foolcdn.com/editorial/images/749323/three-scientists-work-in-laboratory-with-one-looking-down-a-microscope.jpg
Intellia Therapeutics Could Rise 167%, Per Wall Street, But Is It a Buy?

Wall Street analysts are quite bullish right now on gene-editing specialist Intellia Therapeutics (NASDAQ: NTLA) -- expecting, on average, the stock to soar 167% in the coming 12 months. Yet

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Is Pfizer Stock a Buy Now?: https://g.foolcdn.com/editorial/images/749520/gettyimages-an-investor-reads-something-on-his-phone.jpg
Is Pfizer Stock a Buy Now?

Pfizer (NYSE: PFE) sells a wide variety of medicines across treatment areas such as autoimmune diseases and oncology. But it probably is most known for its leading coronavirus vaccine, which helped

Is Pfizer Stock a Buy Now?: https://g.foolcdn.com/editorial/images/749520/gettyimages-an-investor-reads-something-on-his-phone.jpg
Is Pfizer Stock a Buy Now?

Pfizer (NYSE: PFE) sells a wide variety of medicines across treatment areas such as autoimmune diseases and oncology. But it probably is most known for its leading coronavirus vaccine, which helped

2 Top Biotech Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749514/gettyimages-1357572936.jpg
2 Top Biotech Stocks to Buy in October

Biotech stocks offer us a wide range of investing opportunities. You could buy shares of a research stage company and bet on a potential game-changing product that may launch several years from now

2 Top Biotech Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749514/gettyimages-1357572936.jpg
2 Top Biotech Stocks to Buy in October

Biotech stocks offer us a wide range of investing opportunities. You could buy shares of a research stage company and bet on a potential game-changing product that may launch several years from now

2 Top Biotech Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749514/gettyimages-1357572936.jpg
2 Top Biotech Stocks to Buy in October

Biotech stocks offer us a wide range of investing opportunities. You could buy shares of a research stage company and bet on a potential game-changing product that may launch several years from now

Got $1,000? 2 No-Brainer Stocks to Buy: https://g.foolcdn.com/editorial/images/749185/pharmacist-talking-to-patient.jpg
Got $1,000? 2 No-Brainer Stocks to Buy

Sometimes it's hard to know which stocks to pick amid the dozens of options available on equity markets. But occasionally, some companies look so attractive that the decision isn't so difficult

Got $1,000? 2 No-Brainer Stocks to Buy: https://g.foolcdn.com/editorial/images/749185/pharmacist-talking-to-patient.jpg
Got $1,000? 2 No-Brainer Stocks to Buy

Sometimes it's hard to know which stocks to pick amid the dozens of options available on equity markets. But occasionally, some companies look so attractive that the decision isn't so difficult

Got $1,000? 2 No-Brainer Stocks to Buy: https://g.foolcdn.com/editorial/images/749185/pharmacist-talking-to-patient.jpg
Got $1,000? 2 No-Brainer Stocks to Buy

Sometimes it's hard to know which stocks to pick amid the dozens of options available on equity markets. But occasionally, some companies look so attractive that the decision isn't so difficult

3 Top Stocks to Buy in October and Hold Forever: https://g.foolcdn.com/editorial/images/749259/fall-hands-with-laptop.jpg
3 Top Stocks to Buy in October and Hold Forever

Healthcare in the United States is big business: Experts believe the system could generate more than $6 trillion in annual spending by 2030. That's an opportunity for investors to find the key

3 Top Stocks to Buy in October and Hold Forever: https://g.foolcdn.com/editorial/images/749259/fall-hands-with-laptop.jpg
3 Top Stocks to Buy in October and Hold Forever

Healthcare in the United States is big business: Experts believe the system could generate more than $6 trillion in annual spending by 2030. That's an opportunity for investors to find the key

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation: https://g.foolcdn.com/editorial/images/749045/doctor-smiling-and-holding-patients-hand.jpg
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

The healthcare industry evolves rapidly. Those companies that stay relevant often do so by breaking new ground. So it's a good idea for investors looking for exciting healthcare stocks to look at

Humana’s 2024 Medicare Advantage Health Plan Offerings Designed With Affordability, Customer Feedback in Mind: https://mms.businesswire.com/media/20231001029987/en/1900987/5/Humana_AEP_Oct_1_graphic.jpg
Humana’s 2024 Medicare Advantage Health Plan Offerings Designed With Affordability, Customer Feedback in Mind


Leading health and well-being company Humana Inc. (NYSE: HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2024, informed by extensive research regarding

3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street: https://g.foolcdn.com/editorial/images/748648/young-couple-writing-laptop.jpg
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street

Is the stock market surge of 2023 running out of steam? That seems to be the case. The S&P 500 has retreated from the lofty levels of just a couple of months ago.

But there are some stocks that

3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street: https://g.foolcdn.com/editorial/images/748648/young-couple-writing-laptop.jpg
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street

Is the stock market surge of 2023 running out of steam? That seems to be the case. The S&P 500 has retreated from the lofty levels of just a couple of months ago.

But there are some stocks that

Could Viatris Stock Help You Become a Millionaire?: https://g.foolcdn.com/editorial/images/748876/rich-person-standing-next-to-a-jet-and-convertible.jpg
Could Viatris Stock Help You Become a Millionaire?

If you're investing $25,000 in your stock portfolio, then getting that investment to be worth $1 million over time is no simple task. Odds are, you'll have to wait decades for that investment to

Could Viatris Stock Help You Become a Millionaire?: https://g.foolcdn.com/editorial/images/748876/rich-person-standing-next-to-a-jet-and-convertible.jpg
Could Viatris Stock Help You Become a Millionaire?

If you're investing $25,000 in your stock portfolio, then getting that investment to be worth $1 million over time is no simple task. Odds are, you'll have to wait decades for that investment to

3 Magnificent Dividend Stocks to Buy in October: https://g.foolcdn.com/editorial/images/749203/dividend-income.jpg
3 Magnificent Dividend Stocks to Buy in October

There's no better time than October to invest in high-quality dividend stocks. That's because the new month offers a chance to get those dividend payments flowing sooner rather than later.

Three

Stock Split Watch: Is Regeneron Pharmaceuticals Next?: https://g.foolcdn.com/editorial/images/749166/gettyimages-1199696916.jpg
Stock Split Watch: Is Regeneron Pharmaceuticals Next?

Companies generally decide to engage in stock splits after their shares have soared to a level that may put them out of reach for many retail investors. A stock split doesn't change the real market